Strength
160 mg/mL
Manufacturer
UCB, Inc.NDC
50474078185
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/1/2026
Active Ingredients
BIMEKIZUMABApproval Type
Biologic (BLA)
FDA Application
BLA761151On Market Since
10/17/2023
Related Drugs
Same classification
No related drugs found.